|
|
|
Insider
Information: |
Schuth Alexander O. |
Relationship: |
COFO and Secretary |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
178,066 |
|
Indirect Shares
|
523,749 |
|
|
Direct
Value |
$5,398,961 |
|
|
Indirect Value
|
$15,880,070 |
|
|
Total
Shares |
701,815 |
|
|
Total
Value |
$21,279,031 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
9
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
9
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-9.0
|
Percentage
Gain/Loss : |
0.0%
|
-393.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-08-21 |
178,066 |
2024-08-21 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-09-09 |
4 |
AS |
$18.16 |
$136,200 |
I/I |
(7,500) |
610,089 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-11-22 |
4 |
AS |
$18.00 |
$11,628 |
I/I |
(646) |
598,732 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-11-25 |
4 |
AS |
$18.02 |
$254,533 |
I/I |
(14,125) |
584,607 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-11-26 |
4 |
AS |
$18.02 |
$4,127 |
I/I |
(229) |
584,378 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-12-03 |
4 |
AS |
$18.01 |
$18,226 |
I/I |
(1,012) |
583,366 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-12-03 |
4 |
AS |
$18.01 |
$12,805 |
D/D |
(711) |
25,839 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-12-04 |
4 |
AS |
$18.00 |
$47,808 |
I/I |
(2,656) |
580,710 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-12-04 |
4 |
AS |
$18.00 |
$56,178 |
D/D |
(3,121) |
25,839 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-01-04 |
4 |
AS |
$65.17 |
$5,246,408 |
I/I |
(70,000) |
544,562 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-02-04 |
4 |
AS |
$66.65 |
$678,361 |
I/I |
(10,000) |
534,562 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-03-04 |
4 |
AS |
$60.89 |
$610,171 |
I/I |
(10,000) |
531,582 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-05-04 |
4 |
AS |
$55.09 |
$554,864 |
I/I |
(10,000) |
511,582 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-06-04 |
4 |
AS |
$64.35 |
$645,500 |
I/I |
(10,000) |
501,582 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-07-06 |
4 |
AS |
$76.20 |
$762,040 |
I/I |
(10,000) |
491,582 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-08-04 |
4 |
AS |
$51.52 |
$522,233 |
I/I |
(10,000) |
481,582 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-09-07 |
4 |
AS |
$54.70 |
$555,485 |
I/I |
(10,000) |
474,038 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-10-04 |
4 |
AS |
$50.24 |
$505,605 |
I/I |
(10,000) |
473,083 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-11-04 |
4 |
AS |
$52.65 |
$528,404 |
I/I |
(10,000) |
463,083 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-12-06 |
4 |
AS |
$41.82 |
$422,736 |
I/I |
(10,000) |
453,083 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-17 |
4 |
AS |
$29.53 |
$295,339 |
I/I |
(10,000) |
497,173 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-04-12 |
4 |
AS |
$25.04 |
$127,754 |
I/I |
(5,102) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-04-13 |
4 |
AS |
$25.04 |
$122,646 |
I/I |
(4,898) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-05-15 |
4 |
AS |
$28.55 |
$286,044 |
I/I |
(10,000) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-07-17 |
4 |
AS |
$29.60 |
$296,000 |
I/I |
(10,000) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-07-18 |
4 |
AS |
$30.01 |
$291,157 |
I/I |
(9,702) |
518,989 |
0 |
% |
|
93 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|